Log on / register
Feedback | Support | My details
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines.
Tesei A, Ulivi P, Fabbri F, Rosetti M, Leonetti C, Scarsella M, Zupi G, Amadori D, Bolla M, Zoli W
J Transl Med 2005 Feb 3, 3:7
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols
Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P
Journal of Translational Medicine 2008, 6:9 (26 February 2008)
[Full text] [PubMed Central] [PubMed] [Related articles]
2.
37%37%


 Research
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
Tesei A, Rosetti M, Ulivi P, Fabbri F, Medri L, Vannini I, Bolla M, Amadori D, Zoli W
Journal of Translational Medicine 2007, 5:52 (30 October 2007)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.